🕵️ Briacell Therapeutics Corp. ($BCTXL)
SEC insider & ownership activity, last 12 months · CIK 1610820 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Plambeck Jeremy Myung Jae | 100.0% | 13G | Oct 10, 2025 | filing ↗ | |
| Kenneth Griffin | 10.0% | 13G | Jan 23, 2026 | filing ↗ | |
| Citadel Advisors LLC | 10.0% | 13G | Jan 23, 2026 | filing ↗ | |
| Citadel Advisors Holdings LP | 10.0% | 13G | Jan 23, 2026 | filing ↗ | |
| Citadel GP LLC | 10.0% | 13G | Jan 23, 2026 | filing ↗ | |
| Richard Abbe | 9.1% | 13G | Jul 28, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jun 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 26, 2026 | filing ↗ |
| Material agreement (1.01) | May 31, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 31, 2026 | filing ↗ |
| Other events (8.01) | May 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 31, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Shareholder vote (5.07) | Mar 5, 2026 | filing ↗ |
| Other events (8.01) | Feb 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 18, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 13, 2026 | filing ↗ |
| Other events (8.01) | Jan 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 29, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 28, 2025 | filing ↗ |
| Other events (8.01) | Aug 21, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 21, 2025 | filing ↗ |